Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Andrea Fernández-Valero"'
Autor:
Andrea Fernández-Valero, Nerea Peña-Montero, Fuensanta Lima-Rubio, Carolina Gutiérrez-Repiso, Teresa María Linares-Pineda, María José Picón-César, Raquel Sancho-Marín, Francisco J. Tinahones, Sonsoles Morcillo, María Molina-Vega
Publikováno v:
Antioxidants, Vol 12, Iss 11, p 1981 (2023)
Both oxidative stress and intestinal permeability are increased in hyperglycemic situations and have been shown to be reduced by metformin in type 2 diabetes mellitus (T2DM) patients. The aim of this study was to elucidate the effect of metformin on
Externí odkaz:
https://doaj.org/article/ae66abf7e367412b9fd491a154895f6b
Autor:
José Ignacio Martínez-Montoro, José Luis Pinzón-Martín, Miguel Damas-Fuentes, Andrea Fernández-Valero, Francisco J. Tinahones
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Type A insulin resistance (IR) syndrome is a very uncommon genetic disorder affecting the insulin receptor (INSR) gene, characterized by severe IR without the presence of obesity. Patients with this condition will eventually develop diabetes, present
Externí odkaz:
https://doaj.org/article/e50d4f8beeff47d0be372b780ba852e9
Autor:
María Molina-Vega, María J. Picón-César, Carolina Gutiérrez-Repiso, Andrea Fernández-Valero, Fuensanta Lima-Rubio, Stella González-Romero, Isabel Moreno-Indias, Francisco J. Tinahones
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 145, Iss , Pp 112465- (2022)
Background: Metformin, which is known to produce profound changes in gut microbiota, is being increasingly used in gestational diabetes mellitus (GDM). The aim of this study was to elucidate the differences in gut microbiota composition and function
Externí odkaz:
https://doaj.org/article/ff6ab387edbf4bb9adea2651aba7194f
Autor:
María J. Picón-César, Isabel Moreno-Indias, Stella González-Romero, Andrea Fernández-Valero, María Molina-Vega, Francisco J. Tinahones, Carolina Gutiérrez-Repiso, Fuensanta Lima-Rubio
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 145, Iss, Pp 112465-(2022)
Background Metformin, which is known to produce profound changes in gut microbiota, is being increasingly used in gestational diabetes mellitus (GDM). The aim of this study was to elucidate the differences in gut microbiota composition and function i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbfd00a1e85eeff77ce99dfaae2e5dc5
https://hdl.handle.net/10668/22038
https://hdl.handle.net/10668/22038